Fennec Pharmaceuticals (FENC) Cash & Equivalents Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.93% |
| Sep 30, 2025 | -7.93% |
| Jun 30, 2025 | -13.55% |
| Mar 31, 2025 | 18.02% |
| Dec 31, 2024 | 14.30% |
| Sep 30, 2024 | 21.48% |
| Jun 30, 2024 | 25.83% |
| Mar 31, 2024 | 20.40% |
| Dec 31, 2023 | -10.25% |
| Sep 30, 2023 | -12.75% |
| Jun 30, 2023 | -10.22% |
| Mar 31, 2023 | -13.06% |
| Dec 31, 2022 | -3.40% |
| Sep 30, 2022 | 25.16% |
| Jun 30, 2022 | 7.83% |
| Mar 31, 2022 | 41.22% |
| Dec 31, 2021 | 39.98% |
| Sep 30, 2021 | 39.92% |
| Jun 30, 2021 | 39.97% |
| Mar 31, 2021 | 117.87% |
| Dec 31, 2020 | 100.26% |
| Sep 30, 2020 | 89.26% |
| Jun 30, 2020 | 83.65% |
| Mar 31, 2020 | 38.89% |
| Dec 31, 2019 | 42.70% |
| Sep 30, 2019 | 91.42% |
| Jun 30, 2019 | 68.16% |
| Mar 31, 2019 | 72.15% |
| Dec 31, 2018 | 68.79% |
| Sep 30, 2018 | 114.67% |
| Jun 30, 2018 | 91.06% |
| Mar 31, 2018 | 69.74% |
| Dec 31, 2017 | 65.11% |
| Sep 30, 2017 | 27.64% |
| Jun 30, 2017 | 23.33% |
| Mar 31, 2017 | -7.18% |
| Dec 31, 2016 | -5.81% |
| Sep 30, 2016 | -5.98% |
| Jun 30, 2016 | -5.69% |
| Mar 31, 2016 | -35.87% |
| Dec 31, 2015 | -30.82% |
| Sep 30, 2015 | -27.03% |
| Jun 30, 2015 | -23.66% |